Global Bio-chem Technology Group Company Limited (FRA:GLY)
Germany · Delayed Price · Currency is EUR 0.0060
0.00 (0.00%)
At close: Jan 30, 2026
FRA:GLY Income Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 2,289 | 2,001 | 1,374 | 12.71 | 746.55 | 848.87 | |
Revenue Growth (YoY) | 26.88% | 45.65% | 10709.05% | -98.30% | -12.05% | -81.39% |
Cost of Revenue | 1,975 | 1,782 | 1,330 | 4.82 | 721.29 | 779.87 |
Gross Profit | 313.85 | 218.68 | 43.64 | 7.89 | 25.26 | 69 |
Selling, General & Admin | 317.42 | 354.29 | 370.15 | 267.51 | 399.75 | 448.19 |
Other Operating Expenses | -36.35 | - | - | 496.39 | 571.34 | 687.75 |
Operating Expenses | 281.07 | 354.29 | 370.15 | 763.89 | 971.09 | 1,136 |
Operating Income | 32.78 | -135.61 | -326.52 | -756.01 | -945.83 | -1,067 |
Interest Expense | -386.37 | -323.4 | -750.35 | -685.18 | -831.69 | -877.77 |
Interest & Investment Income | - | 0 | 0 | 0.02 | 0.27 | 0.4 |
Earnings From Equity Investments | - | - | - | - | -2 | -2.33 |
Currency Exchange Gain (Loss) | -1.03 | 4.52 | - | - | 1.02 | 13.89 |
Other Non Operating Income (Expenses) | -70.84 | -67.38 | -237.56 | 16.22 | 80.19 | 77.24 |
EBT Excluding Unusual Items | -425.46 | -521.87 | -1,314 | -1,425 | -1,698 | -1,856 |
Merger & Restructuring Charges | - | - | - | - | - | -124.88 |
Gain (Loss) on Sale of Investments | -14.06 | 14.1 | - | - | - | - |
Gain (Loss) on Sale of Assets | 1,962 | 1,962 | 421.87 | - | - | 296.38 |
Asset Writedown | -776.12 | -776.12 | 7.41 | - | -36.46 | - |
Other Unusual Items | 2.15 | 67.39 | 4,586 | - | 1,325 | -726.9 |
Pretax Income | 748.63 | 745.62 | 3,701 | -1,425 | -409.47 | -2,411 |
Income Tax Expense | -23.98 | -23.98 | -42.08 | -46.79 | 25.92 | 22.34 |
Earnings From Continuing Operations | 772.61 | 769.6 | 3,743 | -1,378 | -435.39 | -2,433 |
Earnings From Discontinued Operations | - | - | 481.47 | -141.41 | - | - |
Net Income to Company | 772.61 | 769.6 | 4,225 | -1,520 | -435.39 | -2,433 |
Minority Interest in Earnings | - | - | - | 76.5 | 34.59 | 3.32 |
Net Income | 772.61 | 769.6 | 4,225 | -1,443 | -400.8 | -2,430 |
Net Income to Common | 772.61 | 769.6 | 4,225 | -1,443 | -400.8 | -2,430 |
Net Income Growth | -81.30% | -81.78% | - | - | - | - |
Shares Outstanding (Basic) | 8,929 | 8,929 | 8,907 | 8,907 | 8,907 | 8,508 |
Shares Outstanding (Diluted) | 26,196 | 26,196 | 14,080 | 8,907 | 8,907 | 8,508 |
Shares Change (YoY) | 86.05% | 86.05% | 58.07% | - | 4.70% | 23.86% |
EPS (Basic) | 0.09 | 0.09 | 0.47 | -0.16 | -0.04 | -0.29 |
EPS (Diluted) | 0.03 | 0.03 | 0.29 | -0.16 | -0.04 | -0.29 |
EPS Growth | -89.66% | -90.02% | - | - | - | - |
Free Cash Flow | 108.93 | 76.04 | -94.24 | -94.19 | -501.02 | -43.02 |
Free Cash Flow Per Share | 0.00 | 0.00 | -0.01 | -0.01 | -0.06 | -0.01 |
Gross Margin | 13.71% | 10.93% | 3.18% | 62.06% | 3.38% | 8.13% |
Operating Margin | 1.43% | -6.78% | -23.77% | -5947.64% | -126.69% | -125.69% |
Profit Margin | 33.76% | 38.46% | 307.48% | -11352.91% | -53.69% | -286.26% |
Free Cash Flow Margin | 4.76% | 3.80% | -6.86% | -740.98% | -67.11% | -5.07% |
EBITDA | 165.17 | 77.05 | -43.5 | -447.63 | -567.57 | -635.18 |
EBITDA Margin | 7.22% | 3.85% | -3.17% | - | -76.03% | -74.83% |
D&A For EBITDA | 132.39 | 212.66 | 283.02 | 308.37 | 378.26 | 431.76 |
EBIT | 32.78 | -135.61 | -326.52 | -756.01 | -945.83 | -1,067 |
EBIT Margin | 1.43% | -6.78% | -23.77% | - | -126.69% | -125.69% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.